Medirom Healthcare Technologies Inc (MRM) Fair Value & Analysis
Consumer Cyclical · US · Market cap $9.2M · ISIN US58510H1032
What is Medirom Healthcare Technologies Inc really worth?
Medirom Healthcare Technologies Inc
MRM · US
Below-average quality, and trading another 15% above our fair value of $0.8000.
Risks
Fair value as of: Sep 3, 2026
From 8 valuation models · updated yesterday
Fair value updated Sep 3, 2026, revised from $0.0100 to $0.8000 (+7,900.0%) since Aug 13, 2026. Share price +1.4% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case ($0.8000). The favourable scenario is already priced in.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 3, 2026.
How to read this chart
60‑month range $0.3600 – $12.80 · fair‑value band $0.6000 – $0.8000 · the $0.9223 price screens above the $0.8000 fair value. Dashed = 300-day average. As of Sep 3, 2026.
Analysis
Medirom Healthcare Technologies Inc (MRM) currently trades at $0.9223, while our model-based Fair Value estimate is $0.8000, implying the stock looks roughly 15.3% overvalued today. The Quality Score stands at 18/100 (below-average quality), in the Consumer Cyclical sector. Bull case: the Multiples group reads highest at a median of $0.8100 per share, and 4 of the 8 models we run sit above the $0.9223 price. Bear case: the Earnings-Based group reads lowest at $0.3900, and 4 of the 8 models stay below the price. Evidence for this calculation is low.
Revenue declined 6.7% year over year. It earns a return on equity of 53.2%. Net debt stands at $2.3B. The stock trades on a trailing P/E of 2.4. Fundamentals as of Sep 3, 2026
Our scenario range runs from $0.6000 (bear case) to $0.8000 (bull case); at $0.9223, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 74% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at −11% fair-value upside, at −13%, MRM screens richer than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly $0.2572 per share, which is 32.1 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 8 models by family
Widest divergence: Asset-Based ($113.18) versus Earnings-Based ($0.3900). Highest evidence: Residual Income (70).
Notify me when MRM reaches fair value
Put MRM on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Sep 3, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 18 · Market factors (momentum, volatility) 12
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty.
Full company description
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Medirom Healthcare Technologies Inc reported revenue of $4.0M in FY2025 versus $5.4B in FY2021, a compound −83.5%/yr. Reported net income was $375K in FY2025.
MRM screens 15% overvalued. Compare with Rollins, Inc →
Peer Group
Personal Services · 42 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Personal Services median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Personal Services stocks, each showing price versus our Fair Value estimate (as of Sep 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Rollins, Inc ROL | $35.94 | $21.11 | −41% |
| Service Corporation SCI | $81.43 | $38.27 | −53% |
| Frontdoor, Inc FTDR | $82.59 | $73.81 | −11% |
| H&R Block, Inc HRB | $52.67 | $78.30 | +49% |
| Bright Horizons Family Solutions Inc BFAM | $70.29 | $62.41 | −11% |
| Fu Shou Yuan International Group 1448 | HK$2.64 | HK$4.22 | +60% |
| CEWE Stiftung & Co CWC | €96.00 | €157.28 | +64% |
| Lungyen Life Service Corporation 5530 | 51.20 TWD | 31.33 TWD | −39% |
| Carriage Services, Inc CSV | $34.26 | $27.81 | −19% |
| Musti Group MUSTI | €15.10 | €14.08 | −7% |
Compare Medirom Healthcare Technologies Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Medirom Healthcare Technologies Inc (MRM) overvalued or undervalued?
What is the fair value of MRM?
What is the quality score of MRM?
What is the net profit margin of MRM?
Watch Medirom Healthcare Technologies Inc in the live analysis
One click puts Medirom Healthcare Technologies Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.